Real-world results with IgPro20 for hypo- or agammaglobulinemia in Japan.
Pediatrics international : official journal of the Japan Pediatric Society（2022）
摘要
In Japan, IgPro20 was considered safe and effective among patients with agammaglobulinemia or hypogammaglobulinemia due to PID or SID.
更多查看译文
关键词
agammaglobulinemia,hypogammaglobulinemia,immunoglobulins,postmarketing product surveillance,subcutaneous injections
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要